financetom
Business
financetom
/
Business
/
Darden Restaurants' Second-Quarter Results Likely Pressured by Macro Conditions, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Darden Restaurants' Second-Quarter Results Likely Pressured by Macro Conditions, UBS Says
Dec 9, 2024 12:40 PM

03:07 PM EST, 12/09/2024 (MT Newswires) -- Darden Restaurants' ( DRI ) fiscal second-quarter earnings report due next week will likely reflect a challenging macro environment, though trends at Olive Garden ( DRI ) will likely improve in the second half, UBS Securities said in a Monday note.

The brokerage is modeling Darden's second-quarter same store sales growth at 1.1%, which is below the 1.7% consensus. Its projection reflects a 0.8% rise at Olive Garden ( DRI ) and a 4% improvement at Longhorn Steakhouse.

Investors have indicated a fine dining miss and downside to earnings per share, according to the research report. The brokerage lowered its adjusted earnings per share target to $2 from $2.02, moving further below the $2.03 consensus.

"We expect a challenged macro and casual dining competition likely pressured results across brands," UBS analyst Dennis Geiger said. Darden is scheduled to report results for the second quarter on Dec. 19.

Investors are mixed on the fiscal 2025 guidance, with most expecting management's outlook to be reiterated next week but some anticipating a reduction, according to UBS. Consensus expectations are tracking "below or at the low end" of the company's guidance, Geiger said. Darden reiterated its full-year guidance in September that includes same store sales growth in the 1% to 2% range, total sales between $11.8 billion and $11.9 billion and EPS between $9.40 and $9.60.

UBS expects Olive Garden ( DRI ) trends and market share to improve in the second half of the fiscal year and be complemented by "sustained momentum" at Longhorn. Olive Garden's ( DRI ) improvement would reflect easier year-over-year comparisons, new menu items, and marketing that focuses on price sensitivity, according to Geiger.

Darden's partnership for on-demand Olive Garden ( DRI ) delivery with Uber ( UBER ) is expected to roll out late in 2024, which will provide "notable incremental sales lift" heading into fiscal 2026, he said. The companies in September predicted national expansion would complete by May 2025.

Olive Garden's ( DRI ) same store sales could get a 1% to 2% uplift from the Uber ( UBER ) first-party partnership as sales ramp up, while Darden could eventually expand the service across Darden's other brands, according to UBS.

Price: 168.59, Change: -1.16, Percent Change: -0.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved